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Abstract
Background: Physical activity interventions that are targeted at individuals can be effective in encouraging
people to be more physically active. However, most such interventions are too long or complex and not
scalable to the general population. This trial will test the effectiveness and cost-effectiveness of a very brief
physical activity intervention when delivered as part of preventative health checks in primary care (National
Health Service (NHS) Health Check).
Methods/design: The Very Brief Intervention (VBI) Trial is a two parallel-group, randomised, controlled trial
with 1:1 individual allocation and follow-up at 3 months. A total of 1,140 participants will be recruited from
23 primary care practices in the east of England. Participants eligible for an NHS Health Check and who are
considered suitable to take part by their doctor and able to provide written informed consent are eligible
for the trial. Participants are randomly assigned at the beginning of the NHS Health Check to either 1) the
control arm, in which they receive only the NHS Health Check, or 2) the intervention arm, in which they
receive the NHS Health Check plus ‘Step It Up’ (a very brief intervention that can be delivered in 5 minutes
by nurses and/or healthcare assistants at the end of the Health Check). ‘Step It Up’ includes (1) a face-to-face
discussion, including feedback on current activity level, recommendations for physical activity, and information
on how to use a pedometer, set step goals, and monitor progress; (2) written material supporting the
discussion and tips and links to further resources to help increase physical activity; and (3) a pedometer
to wear and a step chart for monitoring progress.
The primary outcome is accelerometer counts per minute at 3-month follow-up. Secondary outcomes include
the time spent in the different levels of physical activity, self-reported physical activity and economic
measures.
Trial recruitment is underway.
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Discussion: The VBI trial will provide evidence on the effectiveness and cost-effectiveness of the Step It Up
intervention delivered during NHS Health Checks and will inform policy decisions about introducing very brief
interventions into routine primary care practice.
Trial registration: ISRCTN Registry, ISRCTN72691150. Registered on 17 July 2014.
Keywords: Accelerometry, Cost-effectiveness analysis, Pedometer, Physical activity, Primary health care,
Randomised controlled trial, Very brief intervention
Background
Vascular disease, which includes coronary heart disease,
stroke, type 2 diabetes and kidney disease, affects more
than four million people and causes one out of three
deaths and one out of five hospital admissions in
England [1]. Physical inactivity is an important risk fac-
tor, not only for these diseases but for some cancers
too, and is the fourth leading cause of death worldwide
[2, 3]. Physical inactivity has been estimated to cause
9 % of premature mortality worldwide. However, if
physical activity (PA) interventions increased PA by just
10 %, more than 533,000 deaths could be averted each
year [3]. The financial burden from physical inactivity
to the National Health Service (NHS) has been esti-
mated at £1.06 billion annually [1], although these costs
increase significantly when the wider economic costs
are considered [4].The chief medical officer (CMO) for
England [1] recommends that adults should take 30 -
minutes of moderate intensity PA, e.g. brisk walking,
on at least 5 days per week. However, the majority of
adults in the UK do not meet this recommendation [5],
and globally, physical inactivity is on the rise [3].
The National Institute for Health and Care Excellence
(NICE) public health guidance endorses brief PA inter-
ventions in primary care [4]. When brief advice is com-
pared with usual care, the incremental cost-effectiveness
ratio (ICER) of moving one person from an inactive to
active state has been estimated at £1730 [4], although
this figure is dependent on the setting, content of the PA
advice given and the healthcare practitioner delivering
the PA intervention [6]. Therefore, brief advice on PA
promotion can be cost-effective when the longer-term
health benefits and costs are considered [4, 6–8]. In
recent years, emphasis has been placed on promoting
PA interventions along the continuum of individual-
level and population-based interventions. However, time
and cost are still significant constraints on their imple-
mentation [4].
Very brief interventions (VBIs), defined as interven-
tions delivered in a single session of no more than 5 mi-
nutes, could be delivered in primary care consultations
such as NHS health checks and annual disease reviews
[9, 10]. Very few VBIs that promote PA have been
reported in the literature, but where they have, their
content is poorly characterised [9–11]. Few studies
provide a definition of ‘brief ’ or report the duration
of the intervention [8, 11]. Furthermore, many ‘brief ’
interventions are too long or complex to be cost-
effective [6–8, 11–13].
The heterogeneity in methodology and economic
modelling further limits the generalisability of results
and estimates of cost-effectiveness of PA interventions;
usual care is not always the comparator, and relevant
costs are often excluded (e.g. out of pocket expenses
may be significant in the adoption and maintenance of
PA [6]). Measures of effectiveness also vary considerably
between studies and are often based on self-reports
[5, 12, 13]. Self-report PA questionnaires provide useful
information about the types of activities that participants
engage in and can be regarded as complementary to
objective measures such as those derived from accelero-
metry. However, self-reports are subject to recall and
social desirability biases, which may lead to over-
reporting of PA levels [12]. For example, in the 2008
report of the Health Survey for England, the propor-
tions of men and women, respectively, who met the
current recommendations for PA were 39 % and 29 %
when measured by self-report and 6 % and 4 % when
measured by accelerometer [14].
More intensive interventions may be effective at
increasing PA, but the most cost-effective interventions
at the population level are still likely to be those that
require minimal contact [13]. Therefore, an urgent need
exists for more clearly specified PA interventions that
are scalable, effective and cost-effective.
Our 5-year research programme aims to develop and
evaluate very brief interventions that are feasible for pri-
mary care consultations such as NHS Health Checks,
which are available to adults in England between 40 and
74 years of age. The Health Check includes measure-
ment of cholesterol, blood pressure and BMI to assess a
person’s risk of developing vascular disease over 10 years.
Therefore, as their primary purpose is to assess and
manage risk, Health Checks provide an ideal platform
from which to deliver a very brief PA intervention to a
large population of adults.
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We have developed, piloted and evaluated a number
of VBIs [10], and a randomised controlled trial
(ISRCTN02863077) of three promising VBIs has been
undertaken to determine which intervention to take
forward for further testing (Pears S, Bijker M, Morton K,
Vasconcelos J, Parker RA, Westgate K, et al.: A rando-
mised controlled trial of three very brief interventions for
physical activity in primary care, submitted). Consistent
with systematic reviews and meta-analyses of pedometer-
based interventions [15], the pedometer-plus VBI was
considered to be the most practical and feasible and
had the greatest potential to promote change in PA.
The pedometer-plus intervention evaluated in the
previous trial involved a face-to-face discussion on the PA
recommendations and how to use a pedometer and to
set goals and monitor progress. The written material
supported the discussion, and it also provided tips to help
increase PA. However, although participants and practi-
tioners felt that the length of the intervention was about
right, participants thought that the intervention was
too generic and would like to have seen a more tailored
approach. We therefore refined the intervention, without
increasing its duration, to make it more tailored to individ-
uals by emphasising in practitioner training the importance
of (1) providing feedback on participants’ current PA and
(2) emphasising that any increase in steps per day would
be beneficial. The booklet used in the previous trial was re-
fined to include (1) written feedback on the participant’s
current PA level; (2) emphasis that any increase in steps
per day is beneficial; and (3) information on where to find
out about local walking groups and activities and how to
download a pedometer application for smartphones.
The pedometer-plus VBI (Step It Up), delivered at the
end of the NHS Health Check, is to be tested in this rando-
mised controlled trial against the NHS Health Check alone.
Aims
The aims of this trial are as follows:
1. To estimate the effectiveness of a very brief
pedometer-based intervention (Step it Up) in
increasing objectively-measured PA in adults 40–74
years of age attending NHS Health Checks in primary
care compared with the Health Check alone
2. To estimate the cost-effectiveness of this intervention
compared with the Health Check alone from the
perspectives of the NHS and society
3. To assess the mechanisms underlying any
intervention effects and the fidelity of delivery
Methods/design
Design of the study
The VBI Trial is a two parallel-group, randomised,
controlled trial with a 1:1 individual allocation,
comparing the Step It Up intervention delivered in an
NHS Health Check (intervention arm) with the NHS
Health Check alone (usual care control arm). Follow-
up is at 3 months. The design of the study and the
flow of participants are shown in Fig. 1.
Eligibility criteria
Inclusion criteria for the trial map onto those for the
NHS Health Check. Patients aged between 40 and
74 years, who have not been diagnosed with a vascu-
lar disease and are not currently being treated for
relevant risk factors (e.g. raised blood pressure) are
eligible for an NHS Health Check [2] and, therefore,
eligible for inclusion in the trial. However, patients
unable to provide written informed consent (e.g. have
an insufficient grasp of the English language to
understand study procedures) will be excluded, as will
those patients whose GP considers them to be unsuit-
able for inclusion (e.g. because of severe mental im-
pairment or terminal illness).
Practice recruitment and training
Twenty-three primary care practices in urban and
rural areas across the East of England are recruiting
1,140 participants (12 GP practices in Cambridgeshire,
eight in Hertfordshire and Bedfordshire and three in
Norfolk). Initial contact with the practices is through the
regional research network, CRN Eastern. Healthcare prac-
titioners (nurses and/or healthcare assistants) already
trained to deliver NHS Health Checks attend a single
3-hour study training session.
Health practitioners receive a training manual as part of
the training process, and this, along with the face-to-face
session, covers the following: (1) information about the
study aims; (2) information about the importance of pro-
moting PA among adults attending NHS Health Checks;
(3) study documentation, written materials for the partici-
pant, and information on obtaining written informed con-
sent and completing the case report form (CRF) following
Good Clinical Practice guidelines; (4) how to access and
use the web-based randomisation tool to randomly allo-
cate participants to intervention arm ; (5) a detailed pro-
cedure on the Step It Up intervention that describes how
each component of the intervention should be delivered, a
shortened version of the procedure that practitioners can
use as a prompt during the NHS Health Check, and a
script which gives an example of intervention delivery; (6)
a demonstration and practise of patient-centred commu-
nication skills to facilitate behaviour change; (7) role play
by the research team using the script in the training man-
ual to demonstrate the NHS Health Check when all study
and intervention procedures are incorporated; and (8)
practise of the NHS Health Check including all proce-
dures by the healthcare practitioners to consolidate their
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learning and for the research team to provide feedback on
their performance.
To promote fidelity of delivery of the Step It Up
intervention, practitioners are trained to use the brief
procedure, the CRF and the Step It Up intervention
booklet to guide them through the NHS Health
Check and intervention delivery.
Participant recruitment
Recruitment is through the NHS HealthCheck
programme [16]. In order to reduce selection bias, a
subsample of eligible patients is randomly selected
from each participating GP practice. Evidence from
our previous trial suggests a likely 20 % response;
therefore, 250 invitations are expected to yield 50
participants. Where the response is lower than ex-
pected, further subsamples will be generated.
Participant invitation
In addition to the invitation for the NHS Health Check,
an invitation pack that includes the trial information
sheet, an invitation letter and a sample consent form is
sent through the mail to patients. Patients are encouraged
to make an appointment for the NHS Health Check with
their practice, mentioning at the time their interest in tak-
ing part in the trial. If, after 2 weeks, no response has been
received from the patient, a reminder letter is sent.
Mailing information packs through the post with the
NHS Health Check invitation is the preferred method of
recruitment. However, based on procedures used in our
previous trial, GP practices will have the option to use an
alternative method of recruitment as follows: either (1)
mail the study information once a patient has made an ap-
pointment for the NHS Health Check or (2) provided that
patients are given sufficient time to read the information,
hand it to patients in the waiting room as they arrive for
their NHS Health Checks.
Study interventions
Control arm
Participants in the control arm receive only the usual
NHS Health Check. The NHS Health Check is a
Analysed for primary outcome
(n = 394)
Invited to participate 
(n = 5,750)
Completed 3-month follow-up 
(n = 394)
HC only (Control)  
(n = 570)
HC + VBI (Intervention)
(n = 570)
Randomised
(n = 1,140)
Completed 3-month follow-up 
(n = 394)
Analysed for primary outcome
(n = 394)
Fig. 1 Flow diagram for the VBI Trial. With target or estimated numbers. HC, Health Check; VBI, Very Brief Intervention
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series of tests and questions designed to assess the in-
dividual's risk of developing heart disease, stroke, dia-
betes and kidney disease.
Intervention arm
Participants in the intervention arm receive the Step
It Up intervention in addition to the NHS Health
Check. Step It Up is a single-contact intervention that
is delivered by nurses and/or healthcare assistants in
5 minutes at the end of the NHS Health Check. It
consists of the following three components:
1. Face-to-face discussion: The practitioner (a) gives
the patient feedback on their current activity; (b)
gives information about the current PA
recommendations, as advised by the CMO
(30 minutes of moderate-intensity activity on 5
or more days a week or 10,000 steps per day);
(c) shows the patient how to wear and use the
pedometer and encourages them to use it to
monitor the number of steps walked each day;
(d) shows the patient the Step Chart and
encourages them to use it to set a step goal and
record daily steps to monitor whether they
reached that goal; and (e) explains that the
Pedometer Booklet gives tips for how to increase
daily steps by making small changes.
2. Pedometer and Step Chart: A Yamax Digiwalker
SW200 and a printed Step Chart are given to
the patient to use as self-monitoring tools.
3. Step It Up Booklet: The booklet (a) states the UK
government PA recommendations; (b) includes
instructions on how to use the pedometer; (c)
mentions the health benefits of being more active;
(d) provides a graph to show that small changes in
PA can lead to significant health benefits; (e) provides
tips for achieving more steps; and (f) provides links
to other PA resources.
The key behaviour change techniques (BCT) in the
Step It Up intervention, identified from the Behav-
iour Change Technique Taxonomy version 1 [17],
include goal setting, action planning, feedback and
self-monitoring of behaviour. Table 1 provides a full
list and description of the BCTs identified.
Procedure
Randomisation
Randomisation is stratified by primary care practice using
a web-based tool (www.sealedenvelope.com) designed
specifically for the trial. The random allocation ratio
is 1:1 with randomly permuted blocks of sizes 2, 4
and 6 to ensure even randomisation and low predict-
ability of assignment within each stratum.
The nurse or healthcare assistant uses the web-based
program to randomly allocate the patient to either the
control arm (the usual NHS Health Check) or the inter-
vention arm (the usual NHS Health Check with the Step
It Up intervention). Up until this point, the practitioner
and participant are blind to allocation. However, once al-
location is known, practitioners are encouraged to convey
the information positively by describing allocation in
terms of ‘you have been selected to receive the health
check today’ (control arm) or ‘you have been selected to
receive the Step It Up intervention, which we will do at
the end of the health check’ (intervention arm).
The NHS Health Check
Healthcare assistants and nurses conducting the NHS
Health Checks obtain informed consent from participants
following Good Clinical Practice guidelines [18]. Once
consent has been given, participants are asked to complete
a short questionnaire. The information provided in this
questionnaire will be used to characterise the sample and
check baseline comparability between arms. The health-
care practitioner accesses the web-based randomisation
tool at this time to determine to which intervention arm
the participant has been assigned. The rest of the consult-
ation proceeds following the usual NHS Health Check
procedures, and the Step It Up intervention is delivered at
the end to participants in the intervention arm.
Healthcare practitioners also complete a CRF, which
is a written record of the consultation. It is intended
as a guide and provides prompts for each stage of the
consultation. One additional piece of information is
collected: the baseline PA level. This measure is
derived during the NHS Health Check using the GP
PA Questionnaire (GPPAQ) [19] and is used as the
basis for individual feedback at the start of the Step it
Up intervention as well as providing a baseline meas-
ure of PA. The questionnaire asks about the patient’s
PA at work and leisure time in the past week.
Audio-recording of consultations
A random sample of five NHS Health Checks (10 %) will
be selected from each practice for audio-recording and
will include both intervention and control consultations.
This should provide a total of 115 audio-recordings. Par-
ticipants will be asked to confirm their consent verbally
at the start of each audio-recording. Neither the practi-
tioner nor the study team will know in advance which
consultations are to be audio-recorded (this is deter-
mined at the same time as allocation to intervention
arm).
Follow-up
All participants are followed up 3 months after the Health
Check. Participants are asked to wear an accelerometer
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(Actigraph GT3X+ or Actigraph w-GT3X-BT) 1 around
their waist for a period of 7 consecutive days, putting it on
in the morning and taking it off before going to bed. Par-
ticipants are encouraged to go about their activities as
normal during this time but are asked to log the times of
wear during the day (i.e. the time the monitor was put on
and taken off) on the log sheet provided. At the end of the
7 days, participants return the accelerometer in the reply-
paid envelope provided along with the log sheet and a
completed questionnaire. Based on daily variability find-
ings from the previous trial (Pears S, Bijker M, Morton K,
Vasconcelos J, Parker RA, Westgate K, et al.: A rando-
mised controlled trial of three very brief interventions for
physical activity in primary care, submitted), a minimum
of 3 days of activity data each with a minimum of 10 hours
of wear-time data are required to count as a valid record-
ing regardless of how many of the provided days are week-
end days or weekdays. Participants are asked to re-wear
the accelerometer if the returned data fail to reach this
minimum. Non-wear time is determined by 90 minutes or
more of zero counts.
Participants will also be asked to complete a ques-
tionnaire once they have finished wearing the accel-
erometer. The questionnaire consists of three parts:
 Recent physical activity questionnaire (RPAQ).
Self-reported PA over the previous 4 weeks is
measured across four domains (home, work,
Table 1 Content and behaviour change techniques (BCT) of the Step It Up very brief intervention
Content of the face-to-face discussion BCTsa included in the face-to-face discussion
Practitioner Target behaviour: physical activity
• Gives verbal feedback on current PA and informs the participant of whether they are meeting the
PA recommendations
1.1 Goal setting (behaviour)
• Asks the participant if they are aware of the Chief Medical Officer’s PA recommendations and
informs them that the recommendations are for a minimum of 30 minutes of moderate-intensity
activity on 5 or more days of the week, and emphasises that moderate PA is any activity that
raises heart rate, breathing or sweating and includes the activities of daily living
1.4 Action Planning
• Explains the 10,000 steps per day recommendation 2.2 Feedback on behaviour
• Shows the participant how to use the pedometer, and encourages them to use it to monitor
daily steps
2.3 Self-monitoring of behaviour
• Shows the participant the Step Chart and encourages them to use it to set a daily step goal
(starting with a smaller goal) and record daily steps
8.7 Graded tasks
• Explains that the Step It Up Booklet contains information about the health, social, environmental
and emotional benefits of PA; tips for how to increase daily steps by making small changes; and
information about other helpful resources.
12.5 Adding objects to the environment
Target behaviour: Self-monitoring
4.1 Instruction on how to perform the
behaviour
Content of participant materials BCTsa included in the participant materials
Step It Up Booklet containing Target behaviour: physical activity
• Written feedback on current PA. 1.1 Goal setting (behaviour)
• Information on PA recommendations (30 minutes of moderate-intensity activity on 5 or more days
a week; 10,000 steps per day).
1.4 Action Planning
• Instructions on how to use the pedometer and how to self-monitor daily steps. 2.2 Feedback on behaviour
• Information about the health, social, environmental and emotional benefits of PA. 2.3 Self-monitoring of behaviour
• Advice about setting a smaller step goal at first and gradually increasing the goal over time. 5.1 Information about health
consequences
• Tips for how to increase daily steps by making small changes. 5.3 Information about social and
environmental consequences
• Information about other helpful online resources (e.g. where to download a pedometer app, a
website to find a local walking group).
5.6 Information about emotional
consequences
Step Chart 8.7 Graded tasks
• Chart for setting step goals and monitoring daily steps. Target behaviour: Self-monitoring
Pedometer
• A Yamax Digiwalker SW200. 4.1 Instruction on how to perform the
behaviour
aNumbering refers to the Behaviour Change Technique Taxonomy v1 [17]
PA physical activity
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travel and recreation). Section A on home
activities asks questions on the frequency of
television viewing, computer use and stair
climbing. Section B asks questions about the
type of work and the time spent there, as well as
assessing the mode of travel to and from place
of work. The final section asks about the
frequency and duration of frequently performed
recreational activities. When tested against two
gold standard methods of obtaining PA energy
expenditure (PAEE) (doubly labelled water and
combined heartrate and movement sensing), the
RPAQ has been shown to be a valid tool for
ranking individuals according to PAEE [20].
 NHS use, workplace productivity and expenditure
on PA questionnaire. A bespoke questionnaire on
primary and secondary care contacts and
expenditure on health, sports clubs or other
physical activities was developed and piloted
prior to the trial. Work place productivity is
based on an adapted version of the validated
Work Productivity and Activity Impairment
(WPAI) Questionnaire [21].
 Process evaluation. (1) For mechanisms of
impact, a series of questions is used to assess
whether the intervention and materials were
received by participants during the NHS Health
Check and subsequently used, and (2) for
contamination, participants are asked if they
know anyone else who has taken part in the
study, and if yes, whether they were in the
intervention or control group.
Maximising retention
To maximise the response rate, everyone who returns
the accelerometer with valid data and a completed
questionnaire will be entered in a prize draw to receive
one of twenty £20 gift vouchers. Participants are also
given a study ID card and pen at baseline to remind
them of their involvement in the study. To ensure that
timing is convenient to receive the accelerometer, partic-
ipants are contacted (by text, telephone or email) 1 week
before the accelerometer and questionnaire are mailed.
Data management/quality assurance
The randomisation sequence for the web-based random-
isation tool has been generated independently of the
study team. Electronic randomisation records will be
checked against the CRF for fidelity.
The administrative database is managed in-house.
The database has been designed to allow easy entry
of CRF data and the short baseline questionnaire.
Random checks are performed on the entered data
against paper records, and all errors are logged and
corrected.
Double data entry of the follow-up questionnaire
will be done by an experienced independent agency.
The resulting spreadsheets will be interrogated for
invalid values and corrected. In addition, random
checks will be applied as above.
The objective PA data is checked weekly for com-
pleteness, and participants are asked to wear the Acti-
graph monitor for extra days if the minimum wear
time of 10 hours a day over a 3-day period has not
been achieved.
The audio-recordings will be submitted to an inde-
pendent transcription agency and stored on a secure
drive on a University server.
We are promoting walking as a means of increasing
PA, and the duration of the trial for participants is
3 months. Evidence from our previous trial suggested
that the risk of harm or injury to a patient associated
with our trial is low. We do not foresee any events or
circumstances in which we would need to stop the trial
prematurely. No interim analysis or stopping guidelines
have been made prior to the study. However, a trial steer-
ing committee made up of an independent chair, three
independent members, including members of the Public
and Patient Involvement (PPI) panel, representatives from
the funder and the sponsor, and three members of the
research team will oversee all aspects of the trial.
Data analysis will be undertaken on completion of
data collection, database lock and data cleaning.
Confidentiality
The research team will have no access to identifiable
data prior to consent. Study invitations are sent directly
from GP practices. The storage and movement of
identifiable and sensitive data between GP practices
and the research team will be undertaken following the
guidelines and principles of Good Clinical Practice, the
Data Protection Act 1998 and the NHS England confi-
dentiality policy. The chief investigator will be the
custodian of the trial data set, and only authorised
personnel will have access to the (anonymous) data.
Study outcomes
Data are collected by nurses and healthcare assistants
during the NHS Health Check and from question-
naires and accelerometer wear at 3 months post-NHS
Health Check. See Table 2 for a full list of outcome
measures.
Primary outcome
The primary outcome is PA (total body movement)
measured by tri-axial accelerometry (Actigraph GT3X+ or
Actigraph w-GT3X-BT, ActiGraph, Pensacola, Florida,
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USA) expressed as average vector magnitude acceler-
ation (counts per minute). Data collected at 60Hz will
be integrated into 10-second epochs. Non-wear time,
defined as strings of 90 minutes of consecutive zeros
(on the vertical axis), will be excluded, and the
remaining vector magnitude data will be summarised
into average acceleration (counts per minute (cpm)).
Secondary outcomes
Secondary outcomes derived from the accelerometer
data are step counts (average step counts per day)
and the average number of minutes per day spent in
sedentary/light activity (<2,690 cpm); moderate activ-
ity (2,690–6,166 cpm); vigorous activity (≥6,167 cpm);
and moderate or vigorous activity (≥2,690 cpm) [22].
Self-reported PA outcome measures will be obtained
using the validated Recent PA Questionnaire (RPAQ)
[20]. Total Physical Activity Energy Expenditure (PAEE),
domain-specific PAEE (home, work, leisure-time and
commuting) and screen/TV viewing time over the past
4 weeks will be calculated using reported frequency and
duration for each activity, together with estimated
activity-specific metabolic cost [23].
The cost analysis will inform an economic evaluation
and will comprise costs to participants, the NHS (in-
cluding the cost of the intervention itself ), and lost
productivity. Costs to participants will be calculated
from out-of-pocket expenditure reported in question-
naires, adjusted to the price year of the analysis using
the consumer price index (CPI). The value of lost
productivity will be calculated from the WPAI [21].
This estimates reduced productivity whilst at work
(‘presenteeism’) as a self-assessed proportion of max-
imum productivity, as well as days absent from work.
The cost will be calculated as the sum of whole-day
equivalents of work lost multiplied by the median
daily wage in England rate for the price year of the
analysis. The cost to the NHS will be calculated as
the sum of self-reported primary and secondary care
contacts multiplied by representative unit costs per-
taining to the price year of the analysis (e.g. NHS
Reference Costs [24] and Curtis [25]). Finally, the
cost to the NHS of providing the intervention will
be calculated from study records of expenditure on
pedometers, materials and training and the time
required to deliver the VBI.
Process measures
The process evaluation is informed by recent Medical
Research Council guidance [26] and will focus on the
mechanisms underlying any intervention effects and
the implementation (fidelity of delivery) of interven-
tion and control consultations.
Table 2 Study measures
0 months 3 months
Accelerometer measures
Activity counts per minute X
Step counts per day X
Time (minutes/day) in light/sedentary activity X
Time (minutes/day) in moderate activity X
Time (minutes/day) in vigorous activity X
Time (minutes/day) in moderate or vigorous
activity
X
Questionnaire measures
Physical activity energy expenditure (PAEE)
(kj/kg/day)
X
Home-based PAEE (kj/kg/day) X
Work-based PAEE (kj/kg/day) X
Leisure-based PAEE (kj/kg/day) X
Commuting PAEE (kj/kg/day) X
Screen/TV time (hours per day) X
Gender X
Age (calculated from date of birth) X
Ethnicity X
Education X
Employment status X
Household income X
Marital status X
Home ownership X
Vehicle ownership X
Dependents X
Individual deprivation score X
Area deprivation score (Index of Multiple
Deprivation, IMD, based on home postcode)
X
Recall of physical activity (PA) advice X
PA awareness X
Use of intervention materials X
Enactment of behaviour change techniques X
Contamination of sample X
Primary care visits X
Hospital visits X
Out of pocket expenditure X
Work productivity X
National Health Service (NHS) Health Checks
10-year cardiovascular risk score (QRisk2) X
Activity level (Derived from GPPAQ) X
Duration of health check X
Nurse/Healthcare assistant delivery X
Physical activity referrals X
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Mechanisms of impact Variables hypothesised to be
on the causal pathway of any effects include (1) recall
of any PA advice received during the NHS Health
Check consultation (two items); (2) awareness of PA
recommendations and own PA levels (two items); (3)
the use of any materials handed out (e.g. booklet;
three items); and (4) enactment of key behaviour
change techniques included in the intervention (e.g.
goal setting (behaviour) and self-monitoring (behaviour);
four items).
Fidelity of delivery A reliable coding frame will be
developed and piloted for inter-rater reliability to
assess the following variables: (1) duration of the
NHS Health Check and the intervention (if applic-
able); (2) delivery of the standard NHS Health Check
(e.g. taking a blood sample or measuring blood
pressure); (3) delivery of the intervention (e.g. feed-
back on PA levels, mention PA recommendations,
explain the pedometer, prompt goal setting and
self-monitoring, and give a booklet); and (4) contam-
ination, by coding of any intervention-related compo-
nents in the control consultations.
Sample size
A trial of 394 participants per arm followed up is suffi-
cient to detect a 0.2 sd (‘small’) difference in mean
activity between arms (40 accelerometer cpm) based on
the standard deviation of 200 cpm estimated in the
previous trial) with 80 % power. However, allowing for
attrition of 30 % at follow-up (i.e. 30 % of participants
not providing sufficient accelerometer data), an initial
sample size of 570 per arm would give 80 % power to
detect an effect of this size between the two conditions
(alpha = 0.05, two-sided test).
Recruitment and attrition will be monitored. If attri-
tion is lower than 30 % and we anticipate achieving
follow-up of 394 participants per arm with sufficient
accelerometer data from randomising fewer than 570
per arm, participant recruitment will be closed.
Statistical analyses
Full details of the statistical methods are provided in
the statistical analysis plan. The following is a sum-
mary of the main analyses proposed.
We will use analysis of covariance to test for inter-
vention effects on continuous outcomes and quantify
these with differences in means and 95 % confidence
intervals, adjusting for primary care practice, gender
and age. Logistic regression will be used for binary
outcomes. An intention-to-treat approach will be used,
supported by a per protocol analysis for the primary
outcome analysis. All significance tests will be two-
sided and assessed at the 5 % level of significance.
Missing data in the primary outcome will be han-
dled within a sensitivity analysis considering opti-
mistic and pessimistic scenarios for the intervention
effect size in those with missing data and incorporat-
ing baseline predictors of primary outcome missing
status that are differential by group. This analysis will
be undertaken to examine the robustness of the main
analysis result to the ‘missing at random’ (MAR)
assumption. The aim is to adequately explore the
impact of departures from the MAR assumption on
the primary outcome results [27].
Pre-specified subgroup variables will be examined in
relation to the primary outcome and will involve an
initial test of differential intervention effect across the
subgroup variable before summarising the interven-
tion effect within the subgroup categories. These
subgroup variables will include baseline cardiovascular
risk, gender, age (40–59; 60–74 years), ethnic group,
educational qualifications, employment status, house-
hold income, marital status, home ownership, vehicle
ownership, and deprivation score (Index of Multiple
Deprivation (IMD) 2007, derived from the participant’s
home postcode [28]). For a continuous moderator such
as CVD risk, the intervention effect observed in the
highest tertile of the moderator will be estimated with a
95 % confidence interval having an informative width
of +/- 25 thousand activity counts per day.
Incremental effectiveness will also be formally
integrated with incremental cost data forming a
within-trial economic evaluation. This will estimate
the incremental cost per incremental MET(Metabolic
Equivalent of Task)-hour of physical activity gained
(estimated from accelerometer counts). The analysis
will be reported from the perspectives of the NHS
and society. Current guidelines on the conduct and
reporting of economic evaluations will be followed
[29–31]. Analysis of uncertainty will comprise the
estimation of 95 % confidence intervals around incre-
mental costs and outcomes and construction of the
cost-effectiveness acceptability curves.
In addition to the within-trial analysis, results will
be combined with prior data on the costs and effects
of the intervention, and a previously developed model
will be updated with the new evidence to predict the
longer-term costs and outcomes associated with the
intervention and control. This will yield a revised
estimate of the incremental cost per QALY gained.
The revised decision uncertainty will be reported as
an updated cost-effectiveness acceptability curve.
Questionnaire measures relating to the proposed
mechanisms of impact of the intervention (recall of
PA advice, awareness of PA, use of intervention mate-
rials, and enactment of behaviour change techniques)
will be analysed descriptively. Variables that assess
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fidelity of the intervention and control consultations,
derived from coding the audio-recordings, will also be
analysed descriptively. Two overall fidelity scores will
be calculated, expressed as the number of compo-
nents delivered out of those that should be delivered
for (1) the NHS Health Check (intervention and con-
trol consultations) and (2) the intervention (interven-
tion consultations only).
Discussion
The main aims of the VBI trial are to estimate the
effectiveness and the cost-effectiveness of the Step It
Up intervention delivered at the end of an NHS Health
Check compared with the Health Check alone. The
findings of this trial will extend the evidence base on
very brief interventions for PA and will inform policy
decisions about the introduction of very brief PA inter-
ventions into primary care consultations.
The trial has been designed to maximise both internal
and external validity. The participant is randomised by
a web-based program during the consultation. At point
of entry into the trial (i.e. as informed consent is
obtained), neither the participant nor the practitioner is
aware of the group allocation. Once the participant is
allocated, the practitioner tells them which group they
are in. In a trial such as this, practitioners and partici-
pants cannot be blinded to the group allocation.
With individual randomisation of participants (as op-
posed to cluster randomisation of practitioners or prac-
tices), the risk that some of the content of the very brief
intervention may be incorporated into the Health Check
and that participants in the control arm may therefore re-
ceive some intervention content does exist. However, this
did not occur in our trial of a practice nurse-delivered
intervention for medication adherence [32]. The CRF and
the written Step It Up intervention material have been
designed to act as a prompt and guide to the consultation,
thus minimising the risk of contamination. Audio-
recording a sample of consultations will enable fidelity of
delivery to be checked.
The primary outcome measure for this trial is PA ob-
jectively measured using an accelerometer at 3-month
follow-up and expressed in activity counts per minute.
Analysis of accelerometer data will be blinded. Sec-
ondary outcomes include self-report measures of PA,
which provide information on the type and pattern of
activity not otherwise obtainable from accelerometry.
After careful consideration, we decided not to measure
the primary outcome at baseline. A baseline measure
would have a number of advantages: sample size could be
reduced, and an analysis of individual change scores
would be possible. However, pilot work undertaken in
preparation for this trial identified two potential problems
arising from objective measurement of PA at baseline.
First, baseline measurement is logistically difficult and
may compromise uptake of the NHS Health Check and
the flow of participants through the trial. Second, baseline
accelerometry could act as an intervention; that is, some
participants may increase their activity as a result of wear-
ing the device, leaving less scope for our very brief inter-
vention to have an effect [33].
The Step It Up intervention was chosen after a rigorous
selection process [10] and evaluation in a previous trial
(Pears S, Bijker M, Morton K, Vasconcelos J, Parker RA,
Westgate K, et al.: A randomised controlled trial of three
very brief interventions for physical activity in primary
care, submitted) (ISRCTN02863077). The intervention is
well characterised in terms of the component BCTs, is
feasible to deliver in practice with limited training and is
acceptable to both practitioners and participants. External
validity is further increased by using nurses and healthcare
assistants already trained to carry out NHS Health Checks.
The trial team brings together expertise in behavioural
science, intervention development and evaluation, meas-
urement of PA, medical statistics, health economics, and
the design, conduct and analysis of primary care trials. In
designing this trial, we have drawn on our previous work
and on the guidelines and principles of trial reporting laid
out in SPIRIT [34] and CONSORT [35]. See Additional
file 1 for the SPIRIT Checklist.
Trial status
Participant recruitment for this trial is underway.
Endnote
1Two models of Actigraph accelerometers (GT3X+
and w-GT3X+) were used in this trial. Unfortunately,
during the previous trial a number of accelerometers
were ‘lost’ (either in transit or were never returned), and
as a result more accelerometers were purchased to make
up the deficit. By this time, a new generation of Acti-
graph accelerometers had been produced. The manufac-
tures claim the data provided by the GT3X+ and w-
GT3X+, when subjected to the same acceleration envir-
onment, will exhibit outputs within 5 % of each other,
and with randomisation, these are expected to be repre-
sented in the same proportions in the two randomised
groups.
Additional file
Additional file 1: SPIRIT Checklist. (PDF 130 kb)
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